Skip to content

Indole Hallucinogens as Animal Models of Schizophrenia

Edward F. Domino

Animal Models in Human Psychobiology 1976 DOI: 10.1007/978-1-4684-2184-2_14 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics LSD
Keywords Rabbit lung Chronic schizophrenic patient
Citations 3
Key findings Institutional, legal, and funding barriers prevent the integration of clinical access to schizophrenic patients with advanced chemical analysis, stalling research on indole hallucinogens and schizophrenia.

Abstract

To say the least, the literature on indole hallucinogens and schizophrenia is confusing. This is because investigators who have access to schizophrenic patients do not have sophisticated gas chromatographic and mass spectrographic facilities, and those chemically sophisticated researchers who have such analytic facilities do not have access to a suitable patient research population. This situation has existed for some time and probably will continue to exist for a long time. The current nature of psychiatric research strategy, funding, social and legal pressures regarding informed consent and commitment of the mentally ill all combine to retard progress. This situation has become so confusing in the State of Michigan in the last two years that most research with mental patients has stopped. In attempting to protect the rights of the mentally ill, their rights to proper diagnoses and better treatments are being discarded.

Comparable studies

Other narrative reviews on LSD, most cited first.

Citations in the library

Explore topics